Somatostatin Receptor Scintigraphy in Non-Medullary Thyroid Cancer
- 1 January 1996
- journal article
- clinical trial
- Published by S. Karger AG in Digestion
- Vol. 57 (1) , 36-37
- https://doi.org/10.1159/000201391
Abstract
8 patients with papillary cancer (4 with metastases, 4 in remission), 7 follicular cancer patients (6 with metastases), 2 patients with anaplastic thyroid cancer, and 4 other non-medullary thyroid cancer patients all received an intravenous bolus injection of 220 MBq [111In-DTPA-D-Phe1]octreotide. Planar anterior and posterior n camera images of head-neck, chest and abdomen were obtained 24 and 48 h after injection. All primary cancers showed [111ln-DTPA-D-Phe1]octreotide uptake; none occurred in patients in remission. The results were compared with conventional radio-iodine scintigraphy in patients with metastasised, differentiated thyroid cancer.Keywords
This publication has 0 references indexed in Scilit: